Vascular events in transgender people (notice n° 232430)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01564cam a2200229 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250112063006.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Feigerlova, Eva |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Vascular events in transgender people |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2023.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 15 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Hormonal treatment for transgender people is prescribed to encourage the development of secondary sexual characteristics of the desired gender and to reduce the phenotypic expression of the undesired sex. Data in the literature suggest an increase in cardiovascular morbidity and mortality in this population, but the results are inconclusive because there are no long-term prospective studies that include control subjects. Assessment of cardiovascular health in transgender people and preventive actions should integrate several aspects, such as discrimination-related stress, psychological factors, social stigmatization, lifestyle, and access to care. Current health system priorities include improving access to care for this population and improving the skills of health professionals, as well as implementing clinical and basic research studies. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | gender-affirming hormone therapy |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | transgender people |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | vascular function |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | gender-affirming hormone therapy |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | transgender people |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | vascular function |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Sang Thrombose Vaisseaux | Volume 35 | 3 | 2023-05-01 | p. 101-108 | 0999-7385 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/journal-sang-thrombose-vaisseaux-2023-3-page-101?lang=en">https://shs.cairn.info/journal-sang-thrombose-vaisseaux-2023-3-page-101?lang=en</a> |
Pas d'exemplaire disponible.
Réseaux sociaux